Bafna Pharmaceuticals Limited (BOM:532989)
India · Delayed Price · Currency is INR 400.55
+7.85 (2.00%)
At close: Oct 6, 2026
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 9.51 billion as of October 7, 2026. Its market cap has increased by 137.42% in one year.
Market Cap
9.51B
Enterprise Value
9.86B
Revenue
1.43B
Global Rank
n/a
Country Rank
n/a
PE Ratio
122.09
ChartMarket Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 9.51B, an increase of 87,258.68%. That is a compound annual growth rate of 179.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 9.32B | 161.41% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solara Active Pharma Sciences | 32.66B |
| Indoco Remedies | 22.78B |
| Sakar Healthcare | 22.40B |
| Windlas Biotech | 21.01B |
| Beta Drugs | 20.31B |
| Anlon Healthcare | 16.59B |
| Jagsonpal Pharmaceuticals | 15.13B |
| Sigachi Industries | 10.97B |